TrakCel to expand largest commercial CGT integrated partner network to meet industry’s growing needs

• TrakCel expects to increase its pool of integrated CGT partners – already the largest available – by over 40 percent in 2024
• The growing ecosystem supports the OCELLOS cellular orchestration platform, allowing users greater choice and more collaborative opportunities in a cost-efficient manner

Cardiff, UK, February 28, 2024 – TrakCel, the leading and proven provider of cellular orchestration systems to the global cell and gene therapy (CGT) industry, announces the coming expansion of its OCELLOS partner ecosystem, which will bring the total number of integrated partners to 20 by the end of 2024. The growth will mean developers using OCELLOS for cellular orchestration will have even more options for the complex management required to manufacture CGTs. The OCELLOS network already includes the broadest choice of integrated supply chain partners in the industry, including partners for logistics, hub services, labelling, manufacturing execution systems (MES), enterprise resource planning (ERP) and contract research and manufacturing organizations.

TrakCel supports more than 25 CGTs with its OCELLOS system at every step of clinical development, including many that have progressed through multiple stages to commercialization. With the most commercial deployments in the industry, TrakCel's platform continues to lead the way in supporting the advancement of life-saving therapies. Given its track record of sustainable growth, the company will continue building its integrated network with confidence by more than 40 percent this year.

OCELLOS users can expect full support from each integrated partner, which has been the case for existing partners such as Lonza, Cencora, QuickStat, Marken, Biocair, Körber, and Cardinal Health. TrakCel ensures each partner has a dedicated technical contact and proactive liaison for product development on hand, alongside training programmes when necessary. This ensures that OCELLOS remains the data consolidation point at the centre of the manufacturing process. TrakCel’s broad customer base incentivizes partners to maintain optimal operability, and in turn, its large network of partners enhances the ability of OCELLOS to meet the variety of CGT developer needs in order to support clinical and commercial operations.

“For many advanced therapy developers, scaling out from clinical trials and into commercialization requires more partners. Leveraging our expanded ecosystem allows OCELLOS users to advance without the need for bespoke systems requiring expensive, complex and difficult-to-manage integrations,” says Chris Came, VP Relationship Management, TrakCel. “Working with OCELLOS means reassurance that as they grow, CGT developers will have the support needed for the vital work of bringing new life-saving medicines to patients.”

About TrakCel

TrakCel is the market leading developer of integrated cell orchestration solutions and services. TrakCel has specifically designed these solutions to manage the international autologous and allogeneic cell, gene and immunotherapy value and supply chains. Its orchestration platform has evolved in collaboration with, and is increasingly adopted by, leading companies in the cell, gene and immunotherapy industries. The service portfolio includes training, support and consultancy offerings, all tailored to the unique needs of the CGT sector and drawing on TrakCel’s extensive experience in the industry.

TrakCel’s SaaS solutions enable real-time control for all organizations working across the entire therapeutic value chain. This control includes patient eligibility (commercial) and enrolment, sample collection, manufacturing and treatment delivery. TrakCel aims to enable accelerated global scale-up and scale-out of cell and gene therapy products, increasing efficiency and decreasing complexity, while safeguarding Chain of Custody (CoC), Chain of Identity (CoI) and audit trail for efficiency, compliance and traceability. Founded in 2012, TrakCel is headquartered in Cardiff, UK with offices in the US. For more information, visit www.trakcel.com.